Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 944

1.

Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.

Flueck C, Frank G, Smith T, Jafarshad A, Nebie I, Sirima SB, Olugbile S, Alonso P, Tanner M, Druilhe P, Felger I, Corradin G.

Vaccine. 2009 May 5;27(20):2653-61. doi: 10.1016/j.vaccine.2009.02.081. Epub 2009 Mar 6.

PMID:
19428875
2.

Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.

Tonhosolo R, Wunderlich G, Ferreira MU.

J Eukaryot Microbiol. 2001 Sep-Oct;48(5):556-64.

PMID:
11596920
3.

Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.

Lalitha PV, Biswas S, Pillai CR, Saxena RK.

Vaccine. 2008 Aug 18;26(35):4526-35. doi: 10.1016/j.vaccine.2008.06.031. Epub 2008 Jun 30.

PMID:
18590786
4.

Strain-specific humoral response to a polymorphic malaria vaccine.

Flück C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, Anders R, Saul A, Genton B, Felger I.

Infect Immun. 2004 Nov;72(11):6300-5.

5.

Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice.

Mata E, Carcaboso AM, Hernández RM, Igartua M, Corradin G, Pedraz JL.

Vaccine. 2007 Jan 15;25(5):877-85. Epub 2006 Sep 20.

PMID:
17070628
6.

Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria.

al-Yaman F, Genton B, Anders R, Taraika J, Ginny M, Mellor S, Alpers MP.

Parasite Immunol. 1995 Sep;17(9):493-501.

PMID:
8552419
7.
8.

Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity.

Flück C, Schöpflin S, Smith T, Genton B, Alpers MP, Beck HP, Felger I.

Infect Genet Evol. 2007 Jan;7(1):44-51. Epub 2006 May 2.

PMID:
16647307
9.
10.

Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology.

Okitsu SL, Mueller MS, Amacker M, Vogel D, Westerfeld N, Robinson JA, Zurbriggen R, Pluschke G.

Hum Vaccin. 2008 Mar-Apr;4(2):106-14. Epub 2007 Oct 18.

PMID:
18382133
11.
12.

Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.

Enders B, Hundt E, Knapp B.

Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:413-22.

13.

Recombinant protein vaccines against the asexual blood stages of Plasmodium falciparum.

Anders RF, Adda CG, Foley M, Norton RS.

Hum Vaccin. 2010 Jan;6(1):39-53. Epub 2010 Jan 19. Review.

PMID:
20061790
14.
15.

Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.

Bermúdez A, Reyes C, Guzmán F, Vanegas M, Rosas J, Amador R, Rodríguez R, Patarroyo MA, Patarroyo ME.

Vaccine. 2007 May 30;25(22):4487-501. Epub 2007 Mar 26.

PMID:
17403557
16.

Humoral immune responses during a malaria vaccine trial in Tanzanian infants.

Galindo CM, Acosta CJ, Schellenberg D, Aponte JJ, Roca A, Oettli A, Urassa H, Armstrong Schellenberg J, Kahigwa E, Ascaso C, Mshinda H, Lwilla F, Vidal J, Menendez C, Tanner M, Alonso PL.

Parasite Immunol. 2000 Sep;22(9):437-43.

17.

Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice.

Balam S, Jafarshad A, Servis C, Frank G, Reed S, Pink R, Druilhe P, Spertini F, Corradin G.

Vaccine. 2016 Mar 18;34(13):1566-74. doi: 10.1016/j.vaccine.2016.02.013. Epub 2016 Feb 11.

PMID:
26874325
18.

Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes.

Charoenvit Y, Fallarme V, Rogers WO, Sacci JB Jr, Kaur M, Aguiar JC, Yuan LF, Corradin G, Andersen E, Wizel B, Houghten RA, Oloo A, De la Vega P, Hoffman SL.

Infect Immun. 1997 Aug;65(8):3430-7.

19.

High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.

Reddy SB, Anders RF, Beeson JG, Färnert A, Kironde F, Berenzon SK, Wahlgren M, Linse S, Persson KE.

PLoS One. 2012;7(2):e32242. doi: 10.1371/journal.pone.0032242. Epub 2012 Feb 21.

20.

Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2.

Felger I, Steiger S, Hatz C, Smith T, Beck HP.

Parasite Immunol. 2003 Nov-Dec;25(11-12):531-43.

Supplemental Content

Support Center